INJUSD denotes the market price of Injective Protocol’s native token, INJ, quoted in US dollars. It reflects the amount of USD required to buy one INJ on exchanges where the token is listed.
Injective Protocol is a blockchain-based decentralized exchange and derivatives platform built as a layer-1 using Tendermint and Cosmos interoperability. The project was founded by Eric Chen and Albert Chon and emerged in the late 2010s, with its mainnet and token distribution becoming active in subsequent years. INJ serves utility and governance roles on the network and is issued with a capped supply, enabling staking, protocol governance, and fee settlement.
The INJUSD rate is determined by market forces across spot and derivatives venues: order book liquidity, trading volume, and participants’ buy and sell interest. On-chain activity, protocol upgrades, token unlocks, macroeconomic developments, and broader crypto market sentiment also influence price movements, as do exchange listing changes and regulatory news.
INJUSD is used for price discovery, trading, hedging, and portfolio allocation by retail and institutional participants. It also provides a reference for valuing staking rewards, governance positions, and derivatives contracts tied to the Injective ecosystem.
As with other cryptocurrencies, INJUSD can exhibit significant volatility; liquidity varies by exchange and time, affecting spreads and execution risk for market participants.